Antti Pertovaara Selected Research

Antti Pertovaara Research Topics

Disease

64	Pain (Aches) 01/2023 - 09/2002
33	Hypersensitivity (Allergy) 12/2022 - 01/2004
17	Hyperalgesia 11/2023 - 05/2002
14	Neuralgia (Stump Neuralgia) 12/2022 - 01/2004
7	Chronic Pain 11/2023 - 10/2004
6	Peripheral Nervous System Diseases (PNS Diseases) 12/2014 - 06/2007
6	Sleep Deprivation 10/2013 - 05/2007
5	Inflammation (Inflammations) 11/2016 - 01/2003
4	Peripheral Nerve Injuries 02/2019 - 05/2007
4	Diabetes Mellitus 01/2017 - 07/2009
4	Facial Pain (Myofacial Pain) 11/2016 - 10/2004
3	Diabetic Neuropathies (Diabetic Neuropathy) 07/2013 - 01/2012
3	Neurogenic Inflammation 09/2011 - 08/2010
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2008
2	Arthritis (Polyarthritis) 10/2013 - 07/2007
1	Knee Osteoarthritis 11/2023
1	Colorectal Neoplasms (Colorectal Cancer) 06/2022
1	Musculoskeletal Pain 09/2018

Drug/Important Bio-Agent (IBA)

11	TRPA1 Cation ChannelIBA 11/2016 - 07/2009
9	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2022 - 09/2002
9	Dopamine (Intropin)FDA LinkGeneric 12/2022 - 09/2004
9	salicylhydroxamic acid (SHAM)IBA 01/2018 - 02/2003
8	Ion Channels (Ion Channel)IBA 10/2013 - 07/2009
7	Analgesics (Analgesic Drugs)IBA 06/2022 - 06/2009
6	atipamezoleIBA 12/2022 - 01/2005
6	AnkyrinsIBA 11/2018 - 03/2011
6	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2014 - 01/2003
5	5-HT1A Serotonin ReceptorIBA 12/2022 - 03/2006
5	Serotonin (5 Hydroxytryptamine)IBA 09/2018 - 06/2007
5	Capsaicin (Zostrix)FDA Link 01/2017 - 07/2004
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2021 - 05/2007
4	Minocycline (Cyclops)FDA LinkGeneric 02/2019 - 12/2010
4	Glutamic Acid (Glutamate)FDA Link 01/2015 - 08/2011
4	radolmidineIBA 02/2013 - 01/2003
3	CarrageenanIBA 11/2023 - 05/2003
3	RacloprideIBA 12/2022 - 03/2005
3	MuscimolIBA 12/2022 - 05/2009
3	CarbenoxoloneIBA 04/2021 - 12/2010
3	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 02/2003
3	N-Methylaspartate (NMDA)IBA 02/2016 - 07/2008
3	Dimenhydrinate (DMH)FDA LinkGeneric 01/2015 - 10/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 04/2011
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2013 - 10/2006
3	Streptozocin (Streptozotocin)FDA Link 03/2013 - 07/2009
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 03/2013 - 05/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2022 - 09/2018
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 12/2022 - 03/2006
2	BicucullineIBA 12/2022 - 05/2009
2	ML 204IBA 06/2022 - 11/2015
2	Dizocilpine Maleate (Dizocilpine)IBA 04/2021 - 02/2019
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 04/2021 - 10/2013
2	CalciumIBA 11/2018 - 07/2013
2	CationsIBA 11/2018 - 07/2013
2	cinnamaldehyde (cinnamic aldehyde)FDA Link 11/2016 - 01/2014
2	Histamine (Histamine Dihydrochloride)FDA Link 02/2016 - 12/2014
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 02/2016 - 12/2014
2	A-960656IBA 02/2016 - 12/2014
2	GalaninIBA 01/2015 - 01/2014
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2015 - 10/2013
2	Pyruvaldehyde (Methylglyoxal)IBA 01/2014 - 07/2013
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2014 - 07/2013
2	PlasticsIBA 09/2013 - 10/2006
2	Adrenergic Agents (Adrenergic Drugs)IBA 09/2013 - 05/2003
2	Opioid Receptors (Opioid Receptor)IBA 07/2012 - 07/2007
2	GABA-A Receptor AgonistsIBA 12/2010 - 05/2009
2	Pentobarbital (Nembutal)FDA Link 06/2010 - 03/2009
2	QuinpiroleIBA 05/2009 - 06/2007
2	Serotonin ReceptorsIBA 06/2008 - 06/2007
1	KaolinIBA 11/2023
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 12/2022
1	Dopamine D2 Receptor AntagonistsIBA 12/2022
1	HC-070IBA 06/2022
1	Chemotactic FactorsIBA 06/2022
1	Netrin-1IBA 06/2022
1	Pregabalin (Lyrica)FDA Link 06/2022
1	Designer DrugsIBA 01/2022
1	isosakuranetinIBA 04/2021
1	5-methylpyrazole-3-carboxylic acidIBA 04/2021
1	naringeninIBA 04/2021
1	N,N-dimethylsphingosineIBA 04/2021
1	PregnenoloneIBA 04/2021
1	N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA 04/2021
1	SphingolipidsIBA 04/2021
1	CytokinesIBA 04/2021
1	Therapeutic UsesIBA 01/2020
1	Ketamine FDA LinkGeneric 01/2020
1	A-317491IBA 01/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2020
1	Purinergic P2X3 ReceptorsIBA 01/2020
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2020
1	tetrapentylammonium (tetrapentylammonium chloride)IBA 02/2019
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 09/2018

Therapy/Procedure

10	Ligation 02/2016 - 05/2002
4	Analgesia 01/2022 - 03/2005
3	Therapeutics 11/2018 - 09/2011
3	Transcranial Magnetic Stimulation 11/2016 - 10/2014
3	Catheters 12/2014 - 12/2010
2	Anesthesia 01/2023 - 06/2010
2	Lasers (Laser) 08/2010 - 03/2006
1	Intra-Articular Injections 11/2023